PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
Antonio RaffoneAntonio TravaglinoGabriele SacconeMassimo MascoloLuigi InsabatoAntonio MolloGiuseppe De PlacidoFulvio ZulloPublished in: Acta obstetricia et gynecologica Scandinavica (2019)
PAX2 seems to behave as a tumor suppressor in endometrial carcinogenesis. PAX2 is an accurate marker of precancerous EH; complete loss of PAX2 and EIN classification appear as the optimal diagnostic criteria.